Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “neurofibromatosis1 (NF1)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT01089101
What this trial is testing

Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma

Who this might be right for
Low Grade GliomaRecurrent Childhood Pilocytic AstrocytomaRecurrent Neurofibromatosis Type 1+3 more
National Cancer Institute (NCI) 217
Not applicableEnded earlyNCT05683678
What this trial is testing

US Selumetinib Registry

Who this might be right for
Neurofibromatosis Type 1Plexiform Neurofibromas
Alexion Pharmaceuticals, Inc. 37
Early research (Phase 1)Study completedNCT00727233
What this trial is testing

Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis Type IPlexiform Neurofibroma
National Cancer Institute (NCI) 9
Not applicableStudy completedNCT03298438
What this trial is testing

Study About Annoucement of the Diagnosis of Neurofibromatosis 1 in de Novo Forms

Who this might be right for
Neurofibromatosis 1Diagnoses DiseasePost Traumatic Stress Disorder
University Hospital, Brest 31
Not applicableEnded earlyNCT00060008
What this trial is testing

Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma

Who this might be right for
Neurofibromatosis Type 1Precancerous Condition
Children's Hospital of Philadelphia 18
Not applicableStudy completedNCT06262113
What this trial is testing

A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1

Who this might be right for
Neurofibromatosis 1
Massachusetts General Hospital 294
Testing effectiveness (Phase 2)Looking for participantsNCT05331105
What this trial is testing

HL-085 in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis 1Plexiform Neurofibromas
Shanghai Kechow Pharma, Inc. 70
Testing effectiveness (Phase 2)Study completedNCT04481048
What this trial is testing

Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis 1
Children's Hospital Medical Center, Cincinnati 25
Not applicableStudy completedNCT04774289
What this trial is testing

Incidence of Malignant Peripheral Nerve Sheath Tumor (MPNST) Development in Participants With Neurofibromatosis Type 1 (NF1) Receiving and Not Receiving Medical Therapies Directed at Plexiform Neurofibromas (PN)

Who this might be right for
Neurofibromatosis 1Peripheral Nerve Neoplasms, Malignant
National Cancer Institute (NCI) 296
Early research (Phase 1)Study completedNCT03649165
What this trial is testing

Evaluate Bioavailability and Food Effect of Selumetinib (AZD6244) in Healthy Male Participants

Who this might be right for
Neurofibromatosis Type 1 (NF1)-Related Plexiform Neurofibromas (PNs)Healthy Participants
AstraZeneca 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT04954001
What this trial is testing

Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis 1Plexiform NeurofibromaNF1
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 160
Testing effectiveness (Phase 2)Study completedNCT02096471
What this trial is testing

MEK Inhibitor PD-0325901 Trial in Adolescents and Adults With NF1

Who this might be right for
Neurofibromatosis Type 1 and Growing or Symptomatic, Inoperable PN
University of Alabama at Birmingham 19
Early research (Phase 1)Active Not RecruitingNCT04590235
What this trial is testing

Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)

Who this might be right for
Neurofibromatosis 1Neurofibroma Plexiform
AstraZeneca 32
Testing effectiveness (Phase 2)Study completedNCT00076102
What this trial is testing

Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis 1Neurofibroma, Plexiform
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT00304083
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
Neurofibromatosis Type 1Sarcoma
Sarcoma Alliance for Research through Collaboration 48
Not applicableStudy completedNCT07327164
What this trial is testing

Precision Medicine for Neurocutaneous Syndromes in Western China

Who this might be right for
Neurocutaneous SyndromesNeurofibromatosis Type 1 (NF1)Tuberous Sclerosis Complex (TSC)+2 more
West China Hospital 1,200
Early research (Phase 1)Study completedNCT00352495
What this trial is testing

Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma

Who this might be right for
Brain and Central Nervous System TumorsNeurofibromatosis Type 1
Children's Oncology Group 26
Not applicableUnknownNCT04860362
What this trial is testing

Pilot Randomized Control Trial of Telehealth Group for Improving Peer Relationships (PEERS) in NF1

Who this might be right for
Neurofibromatosis 1Social Skills
University of Wisconsin, Milwaukee 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07743554
What this trial is testing

Combination of Avutometinib and Defactinib for Treatment of Relapsed, Refractory, Metastatic, or Unresectable Malignant Peripheral Nerve Sheath Tumor

Who this might be right for
MPNST (Malignant Peripheral Nerve Sheath Tumor)
Girish Dhall, MD 23
Testing effectiveness (Phase 2)Study completedNCT00021541
What this trial is testing

R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas

Who this might be right for
Neurofibroma, PlexiformNeurofibromatosis Type I
National Cancer Institute (NCI) 62
Next Page